Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours - Wikidata - awgldk - TriplyDB

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

http://www.wikidata.org/entity/Q35979112

about

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis The role of Merkel cell polyomavirus and other human polyomaviruses in emerging hallmarks of cancer Immune selection in neoplasia: towards a microevolutionary model of cancer development.Glucose-regulated protein 58 modulates β-catenin protein stability in a cervical adenocarcinoma cell line Role of the HLA System in the Pathogenesis of Dupuytren's Disease.Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation.T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression.Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.Tumor immune escape mechanisms: impact of the neuroendocrine system.Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16 Suppression of the CD8 T cell response by human papillomavirus type 16 E7 occurs in Langerhans cell-depleted mice.Classical and non-classical HLA class I aberrations in primary cervical squamous- and adenocarcinomas and paired lymph node metastases.Histone deacetylases and the immunological network: implications in cancer and inflammation.Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies.CIITA versus IFN-gamma induced MHC class II expression in head and neck cancer cells.WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?Selective mechanisms utilized by persistent and oncogenic viruses to interfere with antigen processing and presentation.Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell lines.Human papillomavirus type 16 (HPV 16) E7 and major histocompatibility complex (MHC) class I and II expression in human keratinocytes in culture.Tumour surveillance: missing peptides and MHC molecules.NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients.HLA-DR antigen-negative acute myeloid leukemia.Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated.Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma.Downregulation of TAP1 and TAP2 in early stage breast cancer.MHC class I heavy chain mRNA must exceed a threshold level for the reconstitution of cell surface expression of class I MHC complexes in cells transformed by the highly oncogenic adenovirus 12.Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins.Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.Immunization with tumor-associated epitopes fused to an endoplasmic reticulum translocation signal sequence affords protection against tumors with down-regulated expression of MHC and peptide transporters.Selective upregulation of MHC class I expression in metastatic colonies derived from tumor clones of a murine fibrosarcoma.Frequency of Class I and II HLA alleles in patients with lung cancer according to chemotherapy response and 5-year survival From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology

P2860

Q22253275-71279EE9-1E0A-4D84-9B3D-522A01831F1E Q28083883-C3A8BCAC-9190-4D95-8369-471AA79585BA Q33948688-907A5827-B045-49A0-A926-670F656B3F66 Q34029568-599ED291-23AB-4254-8D67-CAF60ACD3C9C Q34061326-6768D64D-33E3-4AD6-8DE0-17F232831059 Q34432287-33BB217E-53C9-4E31-93E9-014A053AF8B9 Q34452013-36A16DC6-7534-47F3-AC51-8DEA74BA67F9 Q35786324-C85ABE4D-440E-4814-9197-D0BBF13BA527 Q36081450-7103237C-84D2-44CD-B618-5B9C5002756E Q36151380-411344D0-E8C0-4F37-ADB4-5706C4A7FAA9 Q36366222-22E01491-DEB8-4433-BC31-B56AB85882D4 Q36376833-875DFC67-8FA8-4A65-A809-7D615B1DA1C1 Q36622535-5DB30948-924E-4B44-B816-29EE780C54C0 Q37314669-8C1D4B13-F7B3-4335-9064-B349E7B5BDB2 Q37414728-0AA96305-59B1-432F-9ECA-FA6E74BDD05B Q37621256-90D5D783-C2F1-4874-8353-5F6A2AB39E78 Q37939726-AEDBA6D9-3F08-4B91-B9BF-7DCA33CC7C4E Q39875574-94ECB3EB-6F02-4BBA-8D69-B2826B19B6D2 Q39902249-F4893D39-1459-4034-9DB6-4DA10E1606E3 Q40125452-2A046884-3EC3-4741-821D-027FD2B18F29 Q40928716-027E24AF-2FB4-4AB7-9F42-770DE5EB746F Q41121307-76F07D30-2C1A-4147-8069-A5C68814E77A Q41253040-4DA35A5A-00EC-4C25-B6D9-23519276A2CC Q41745124-EDB3159A-1A8F-4D8B-80E7-99F9A5F4AFE1 Q42452613-D0B6342B-DA21-4FE2-812F-58E07861D9DF Q43477895-D21F9EA6-51E2-46EB-BF2C-396E746BA23F Q44630353-43A6B4BB-F1F0-45FE-9A33-1E993232BC40 Q46249516-ADAB01B5-4F29-4734-86A8-C7271667E7C5 Q47112014-9DE23E52-0D5C-41F5-9FF9-DA2339D67B45 Q48010302-087584AB-7E94-496F-A918-DA77B53D2BAC Q51797671-64399021-9706-441A-BE52-C5D44CA06D87 Q52863553-2675760E-565D-4F3F-B8FA-32332628ED5C Q53265013-2631213A-800C-4E2F-B51A-9147A0657691 Q54018506-9BA8D540-582F-4E64-9CD2-8D266E873A57 Q54053683-794AF989-C02F-42A9-AA01-1C317F9D52F6 Q56945687-5F060424-74D3-4145-96EE-20D1B1BC7355 Q58553780-1B1A4CAF-6220-4634-8FD0-EA777D5D932C

P2860

Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours

http://www.wikidata.org/entity/Q35979112

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Differences in MHC and TAP-1 e ...... pared with the primary tumours

@ast

Differences in MHC and TAP-1 e ...... pared with the primary tumours

@en

type

label

Differences in MHC and TAP-1 e ...... pared with the primary tumours

@ast

Differences in MHC and TAP-1 e ...... pared with the primary tumours

@en

prefLabel

Differences in MHC and TAP-1 e ...... pared with the primary tumours

@ast

Differences in MHC and TAP-1 e ...... pared with the primary tumours

@en

P1433

Q35979112-FBD665A4-D6A6-4AE1-AEE9-A1DC2454EE38

P1476

Q35979112-21FA9B61-FC25-47C0-A6AE-3F0F95D4C015

P2093

Q35979112-216B8E2D-0F88-4290-8F62-D1AD48E68F1E

Q35979112-25ED608D-C02A-4C76-9D9B-0E961180CF13

Q35979112-2D469F35-69D5-4260-97EB-7C190D3780AF

Q35979112-40736E77-91C7-4CEF-9CDA-CA0E5C69CF29

Q35979112-58B73B8B-15F8-4F15-AAD6-8F9351415648

Q35979112-B98D1934-C8B7-4445-AA13-235476C524E1

Q35979112-D26A9A6A-3AE2-4A1A-8C92-EEA17EB03DE6

Q35979112-F4A9401F-6E2D-4ACD-9384-5C4F0A49EE58

P2860

Q35979112-015A4082-D59E-4A04-AD7B-8B81BC24E21B

Q35979112-1EFD76E0-9153-4FB3-83D6-5A066A2DC5C0

Q35979112-236EEB41-E7F7-4EC8-AC17-457F6E433406

Q35979112-26CC03FB-337F-438E-9B30-70B0A90095BA

Q35979112-359192DB-263D-49A4-8F48-1193A3B2B5E7

Q35979112-42C5DF87-8C47-4AB3-B80D-C16331D6CABD

Q35979112-4FD4CA96-B5E7-4DA7-9F06-9224B7F55B06

Q35979112-5065B37F-FD18-4E56-BBEC-611A7C711034

Q35979112-50C0550D-3359-43A8-B606-5006667326BB

Q35979112-54699CA4-B5C5-4133-9A1D-B83E690906FA

P2888

Q35979112-CD4471C0-9F67-4D9B-A3B3-4A7B963AFC9D

P304

Q35979112-045188B3-529E-4592-B34C-E597111EFCA0

P31

Q35979112-BD08757D-C4C4-4706-89C3-63A45670CAC8

P356

Q35979112-21914A10-52E9-4028-B65F-FDE51888368E

P407

Q35979112-83E1918D-B471-4B9C-ABD8-6B88D75B1E5B

P433

Q35979112-35B6AECE-C9A1-4292-85DB-BDFCBFC3C060

P478

Q35979112-2FF94CE6-8780-4AD9-9558-13786D3FEE04

P50

Q35979112-4AE44DB5-BE20-4C32-9D00-0EB607F47B7F

P577

Q35979112-CEFB4C25-5FA4-4DD5-864B-25421E6DA1DC

P5875

Q35979112-163A5D71-6766-4378-9168-D910B104320F

P698

Q35979112-47AC9186-EA54-4981-9FAE-90B58AAA20CB

P921

Q35979112-3F16FAD1-C833-459D-9D85-FCF6C848E5DB

P932

Q35979112-5CDEE88B-5CDB-4F3E-879B-21025AB48B32

P356

P1433

British Journal of Cancer

P1476

Differences in MHC and TAP-1 e ...... pared with the primary tumours

@en

P2093

C J Meijer

http://www.w3.org/2001/XMLSchema#string

F V Cromme

http://www.w3.org/2001/XMLSchema#string

J M Walboomers

http://www.w3.org/2001/XMLSchema#string

M J Stukart

http://www.w3.org/2001/XMLSchema#string

M P Gallee

http://www.w3.org/2001/XMLSchema#string

P F van Bommel

http://www.w3.org/2001/XMLSchema#string

P Kenemans

http://www.w3.org/2001/XMLSchema#string

T J Helmerhorst

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of human cancers deficient in antigen processing

Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter

Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters

A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway

Nonradioactive RNA in situ hybridization detection of human papillomavirus 16-E7 transcripts in squamous cell carcinomas of the uterine cervix using confocal laser scan microscopy.

Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

Proteolysis, proteasomes and antigen presentation.

Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions.

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.

An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells

P2888

P304

1176-1181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1994.231

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

1994-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15000255

http://www.w3.org/2001/XMLSchema#string

P698

8198988

http://www.w3.org/2001/XMLSchema#string

P921

P932

1969430

http://www.w3.org/2001/XMLSchema#string